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Abstract 
Objectives: We present the case of a 41-year-old man with sudden development of 
left hemiparesis due to infarction of the right middle cerebral artery, successfully 
treated with intravenous alteplase.  
Methods and Results: Transthoracic echocardiography showed small mass in the left 
ventricle, the patient underwent surgical operation, and the histological examination 
confirmed the diagnosis of the papillary fibroelastoma. 
Conclusion: It remains to be investigated whether heart ultrasound should be included 
as an evaluation prior intravenous thrombolysis in selected patients with stroke 
because of apparently increased risk of bleeding. However intravenous thrombolysis 
should not be postponed due to lengthy investigation because of its potential in 
reducing morbidity of stroke patients. 
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Causes of ischemic stroke in young differ from those in older patients.1 As 
intravenous thrombolysis, as the only currently widely available treatment for stroke 
must be performed within 3 hours from symptoms onset, usually there is no time to 
exclude all these conditions which could potentially be harmful. 
 
Case report 
A 41 year old man, without history of serious illness and known cerebrovascular risk 
factors was admitted after sudden development of left hemiparesis. Brain multi-sliced 
computed tomography (MSCT) showed no early stroke signs (Figure 1A). NIHSS 
was 13, and according to our protocol we started thrombolysis with intravenous tissue 
plasminogen activator (tPA), 105 minutes after symptoms onset. Twelve hours later 
follow-up MSCT showed infarction in the territory of the right MCA, without 
bleeding (Figure 1B), and NIHSS was 2. Further investigation showed 
hypercholesterolemia, doppler sonography was normal, coagulation tests were 
normal. Electrocardiogram showed no signs of atrial flutter. Two days after admission 
transthoracal echo (TTE) visualized a small (1,5 x 0,9 cm) mass on the gracile 
peduncule connected to posteromedial papillary muscle and tendinous chords (Figure 
2). An urgent operation was successfully performed, without neurological 
deterioration. Histological examination of the removed mass was consistent with 
papillary fibroelastoma (PFE) (Figure 3). Follow-up cardiac status, including control 
TTE was normal, and the patient was transferred to a rehabilitation facility. 
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Discussion 
Cardiac PFE is a rare primary cardiac tumor and, unlike myxoma, the embolization is 
uncommon.2 Mostly it is described in patients over 50 years old, with no sex 
preference, has no symptoms or becomes evident during investigation after stroke.2,3  
However, although rare, stroke is possible sequel of cardiac PFE. A fibrin thrombus 
attached to the circumference of the PFE, as well as the PFE itself, can be a source of 
embolic material.2 Similarily, emboli from atrial myxomas may be composed of either 
thrombus, tumor itself, or both.4 In either case, tumor emboli without fibrin thrombus 
are unlikely to lyse with thrombolytic therapy. Despite this, anticoagulant therapy is 
recommended for stroke patients with PFE up to the day of the surgical resection.5 
Clinical symptoms and physical examination in presented patient did not suggest a 
diagnosis of tumor emboli. There are 2 reports about intra-arterial thrombolysis in 
patients with atrial myxoma and PFE, which were successfully recanalized,3,6 and 
only one case of myxoma in which an intravenous thrombolytic agents have been 
used with complete recovery of neurological deficit and without complications.7 
Another report showed a patient treated with intravenous tPA who developed 
hemorrhage remote from the location of ischemic stroke.8 These authors suggested 
that intra-arterial local thrombolysis may be a preferable alternative because of greater 
risk of hemorrhage from occult tumor emboli or microaneurysms. 
Although, in our patient, MSCT in a control interval visualized an infarction in the 
territory of the right middle cerebral artery, neurological recovery was almost 
complete. Our patient did not have hypertension, diabetes, had negative family history 
for cerebrovascular disease and he didn’t smoke. Coagulation tests and repeated 
electrocardiogram were normal, as well color-doppler ultrasound of carotid and 
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vertebral arteries. We are routinely performing TTE in all patients with stroke, which 
in this case revealed a small mass on the gracile peduncule connected to posteromedial 
papillary muscle and tendinous chords. In a case-control study, the sensitivity of TTE 
for PFE was 61.9%, while that of transesophageal echocardiography (TEE) was 
76.6%.9 Because the tumor was clearly visualized by TTE, and there were no signs of 
other cardiac abnormalities we did not perform TTE. Based on above mention tests 
and absence of all other stroke risk factors we concluded that PFE was source of 
emboli and cardiac surgery was performed. The effectivnes of intravenous 
thrombolysis can be explained that a fibrin thrombus was attached to the 
circumference of the PFE, which led to significant improovement in this case. 
Different histological properties of myxomas and PFE may, in part, explain the 
different propensity for bleeding after intravenous thrombolysis.  
In conclusion, cardiac tumor emboli are very rare, but the first clinical presentation 
can be neurological. PFE is a rare but potentially treatable cause of embolic stroke. 
There are no randomized controlled studies of intravenous thrombolysis in patients 
with cardiac tumors due to relative small number of patients so risk of bleeding is 
hard to define. To the best of our knowledge, this case is a first reported case of PFE 
successfully treated with intravenous thrombolysis. Although one case report showed 
bleeding after intravenous thrombolysis in patient with cardiac myxoma, the benefit 
of this therapy far outweighs the risk, so intravenous thrombolysis should not be 
postponed due to lengthy investigation because of its potential in reducing morbidity 
of stroke patients. 
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Figures 
 
Figure 1. A) Brain CT on admission; B) Brain CT 12 hours after thrombolysis 
showing infarction in the territory of the right MCA, without bleeding. 
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Figure 2. Transthoracal echocardiogram, apical three chamber view showing floating 
tumor in the left ventricular cavity. FE = tumor (fibroelastoma); LV = left ventricle, 
LA = left atrium; Ao = aorta; RV = right ventricle. 
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Figure 3. Histological examination shows core of connective connective tissue 
surrounded by endocardic cells (H&E). 
 
 
 
